Numerous studies have reported that targets such as NF-κB and Nrf2 could be affected by different types of probiotics in animal models of depression (Gao et al., 2021; Zhu L. et al., 2023; Fatima et al., 2023; Rezaie et al., 2024). Here, NFKB1 is linked to depressive symptom measurement.